|
1
|
Ferrara F and Schiffer CA: Acute myeloid
leukaemia in adults. Lancet. 381:484–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kapranov P, Cheng J, Dike S, Nix DA,
Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J,
Hofacker IL, et al: RNA maps reveal new RNA classes and a possible
function for pervasive transcription. Science. 316:1484–1488. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perez DS, Hoage TR, Pritchett JR,
Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS and
Smith DI: Long, abundantly expressed non-coding transcripts are
altered in cancer. Hum Mol Genet. 17:642–655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Louro R, Smirnova AS and Verjovski-Almeida
S: Long intronic noncoding RNA transcription: Expression noise or
expression choice? Genomics. 93:291–298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Morales D Rivea, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Feng T, Lian Y, Zhang G, Garen A and
Song X: Role of human noncoding RNAs in the control of
tumorigenesis. Proc Natl Acad Sci USA. 106:12956–12961. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Verhaegh GW, Verkleij L, Vermeulen SH, den
Heijer M, Witjes JA and Kiemeney LA: Polymorphisms in the H19 gene
and the risk of bladder cancer. Eur Urol. 54:1118–1126. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu Z, Song L, He J, Sun Y, Liu X and Zou
X: Ectopic expressed long non-coding RNA H19 contributes to
malignant cell behavior of ovarian cancer. Int J Clin Exp Pathol.
8:10082–10091. 2015.PubMed/NCBI
|
|
10
|
Berteaux N, Lottin S, Monté D, Pinte S,
Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and
Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer
cell proliferation through positive control by E2F1. J Biol Chem.
280:29625–29636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu T, Qu L, He G, Tian L, Li L, Zhou H,
Jin Q, Ren J, Wang Y, Wang J, et al: Regulation of laryngeal
squamous cell cancer progression by the lncRNA
H19/miR-148a-3p/DNMT1 axis. Oncotarget. 7:11553–11566. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L, Cai Y, Zhao X, Zhang J, Liu J,
Zhen H, Wang T, Tang X, Liu Y and Wang J: Down-regulated long
non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma.
Neoplasma. 62:412–418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou X, Ye F, Yin C, Zhuang Y, Yue G and
Zhang G: The interaction between MiR-141 and lncRNA-H19 in
regulating cell proliferation and migration in gastric cancer. Cell
Physiol Biochem. 36:1440–1452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang E, Li W, Yin D, De W, Zhu L, Sun S
and Han L: c-Myc-regulated long non-coding RNA H19 indicates a poor
prognosis and affects cell proliferation in non-small-cell lung
cancer. Tumour Biol. 37:4007–4015. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Long non-coding RNA H19 increases bladder cancer metastasis by
associating with EZH2 and inhibiting E-cadherin expression. Cancer
Lett. 333:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dalton WT Jr, Ahearn MJ, McCredie KB,
Freireich EJ, Stass SA and Trujillo JM: HL-60 cell line was derived
from a patient with FAB-M2 and not FAB-M3. Blood. 71:242–247.
1988.PubMed/NCBI
|
|
18
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Upregulated H19 contributes to bladder cancer cell proliferation
by regulating ID2 expression. FEBS J. 280:1709–1716. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li K, Yao L, Chen L, Cao ZG, Yu SJ, Kuang
XY, Hu X and Shao ZM: ID2 predicts poor prognosis in breast cancer,
especially in triple-negative breast cancer, and inhibits
E-cadherin expression. Onco Targets Ther. 7:1083–1094.
2014.PubMed/NCBI
|
|
20
|
Wang C, Chen Q, Hamajima Y, Sun W, Zheng
YQ, Hu XH, Ondrey FG and Lin JZ: Id2 regulates the proliferation of
squamous cell carcinoma in vitro via the NF-κB/Cyclin D1 pathway.
Chin J Cancer. 31:430–439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
May AM, Frey AV, Bogatyreva L,
Benkisser-Petersen M, Hauschke D, Lübbert M, Wäsch R, Werner M,
Hasskarl J and Lassmann S: ID2 and ID3 protein expression mirrors
granulopoietic maturation and discriminates between acute leukemia
subtypes. Histochem Cell Biol. 141:431–440. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang WC, Fu WM, Wang YB, Sun YX, Xu LL,
Wong CW, Chan KM, Li G, Waye MM and Zhang JF: H19 activates Wnt
signaling and promotes osteoblast differentiation by functioning as
a competing endogenous RNA. Sci Rep. 6:201212016. View Article : Google Scholar : PubMed/NCBI
|
